Literature DB >> 3571394

Solid-phase extraction of vinblastine and vincristine from plasma and urine: variable drug recoveries due to non-reproducible column packings.

D E Vendrig, J J Holthuis, V Erdélyi-Tóth, A Hulshoff.   

Abstract

A sensitive and selective high-performance liquid chromatographic (HPLC) method for the determination of vinblastine and vincristine in plasma and urine is described. The drugs are isolated from 1.0 ml of the biological fluid with a solid-phase extraction column (Bond-Elut Diol). The HPLC method was combined with electrochemical detection at +850 mV versus an Ag/AgCl reference electrode. The detection limit is 100 pg for vinblastine and 250 pg for vincristine with a signal-to-noise ratio of 3, which permits the determination of these compounds in biological fluids at the nanogram level. Evaluation of the isolation method revealed that the drug recoveries and the reproducibility of the extraction procedure depend on the batch number of the solid-phase extraction column used.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3571394     DOI: 10.1016/0378-4347(87)80027-0

Source DB:  PubMed          Journal:  J Chromatogr


  2 in total

Review 1.  Preclinical and clinical pharmacology of vinca alkaloids.

Authors:  X J Zhou; R Rahmani
Journal:  Drugs       Date:  1992       Impact factor: 9.546

2.  A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma.

Authors:  J Berlin; A C King; K Tutsch; J W Findlay; P Kohler; M Collier; N J Clendeninn; G Wilding
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.